List of Tables
Table 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 75IU
Table 3. Key Players of 150IU
Table 4. Key Players of Others
Table 5. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2019-2024)
Table 9. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2025-2030)
Table 11. Recombinant Human Follicle-stimulating Hormone Market Trends
Table 12. Recombinant Human Follicle-stimulating Hormone Market Drivers
Table 13. Recombinant Human Follicle-stimulating Hormone Market Challenges
Table 14. Recombinant Human Follicle-stimulating Hormone Market Restraints
Table 15. Global Recombinant Human Follicle-stimulating Hormone Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players (2019-2024)
Table 17. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2023)
Table 18. Ranking of Global Top Recombinant Human Follicle-stimulating Hormone Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Recombinant Human Follicle-stimulating Hormone Product Solution and Service
Table 22. Date of Enter into Recombinant Human Follicle-stimulating Hormone Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Recombinant Human Follicle-stimulating Hormone Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2019-2024)
Table 26. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2025-2030)
Table 28. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2019-2024)
Table 30. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2025-2030)
Table 32. North America Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030) & (US$ Million)
Table 47. Merck Company Detail
Table 48. Merck Business Overview
Table 49. Merck Recombinant Human Follicle-stimulating Hormone Product
Table 50. Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Ferring Company Detail
Table 53. Ferring Business Overview
Table 54. Ferring Recombinant Human Follicle-stimulating Hormone Product
Table 55. Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 56. Ferring Recent Development
Table 57. Livzon Company Detail
Table 58. Livzon Business Overview
Table 59. Livzon Recombinant Human Follicle-stimulating Hormone Product
Table 60. Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 61. Livzon Recent Development
Table 62. Gedeon Richter Company Detail
Table 63. Gedeon Richter Business Overview
Table 64. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product
Table 65. Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 66. Gedeon Richter Recent Development
Table 67. GenSci Company Detail
Table 68. GenSci Business Overview
Table 69. GenSci Recombinant Human Follicle-stimulating Hormone Product
Table 70. GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 71. GenSci Recent Development
Table 72. Teva Company Detail
Table 73. Teva Business Overview
Table 74. Teva Recombinant Human Follicle-stimulating Hormone Product
Table 75. Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 76. Teva Recent Development
Table 77. ChangChun High & New Technology Company Detail
Table 78. ChangChun High & New Technology Business Overview
Table 79. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product
Table 80. ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 81. ChangChun High & New Technology Recent Development
Table 82. ABL Company Detail
Table 83. ABL Business Overview
Table 84. ABL Recombinant Human Follicle-stimulating Hormone Product
Table 85. ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 86. ABL Recent Development
Table 87. Scripps Laboratories Company Detail
Table 88. Scripps Laboratories Business Overview
Table 89. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product
Table 90. Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 91. Scripps Laboratories Recent Development
Table 92. Alphamab Oncology Company Detail
Table 93. Alphamab Oncology Business Overview
Table 94. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product
Table 95. Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 96. Alphamab Oncology Recent Development
Table 97. Hunan Jingfeng Pharmaceutical Company Detail
Table 98. Hunan Jingfeng Pharmaceutical Business Overview
Table 99. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product
Table 100. Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 101. Hunan Jingfeng Pharmaceutical Recent Development
Table 102. Qilu Pharmaceutical Company Detail
Table 103. Qilu Pharmaceutical Business Overview
Table 104. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product
Table 105. Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 106. Qilu Pharmaceutical Recent Development
Table 107. Beijing SL Pharmaceutical Company Detail
Table 108. Beijing SL Pharmaceutical Business Overview
Table 109. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product
Table 110. Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)
Table 111. Beijing SL Pharmaceutical Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Recombinant Human Follicle-stimulating Hormone Market Share by Type: 2023 VS 2030
Figure 3. 75IU Features
Figure 4. 150IU Features
Figure 5. Others Features
Figure 6. Global Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application: 2023 VS 2030
Figure 8. Infertility Treatment Case Studies
Figure 9. Assisted Reproductive Technology Case Studies
Figure 10. Recombinant Human Follicle-stimulating Hormone Report Years Considered
Figure 11. Global Recombinant Human Follicle-stimulating Hormone Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Recombinant Human Follicle-stimulating Hormone Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region: 2023 VS 2030
Figure 14. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players in 2023
Figure 15. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2023
Figure 17. North America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2019-2030)
Figure 19. United States Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Recombinant Human Follicle-stimulating Hormone Market Share by Country (2019-2030)
Figure 23. Germany Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Share by Region (2019-2030)
Figure 31. China Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2019-2030)
Figure 39. Mexico Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Share by Country (2019-2030)
Figure 43. Turkey Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 46. Ferring Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 47. Livzon Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 48. Gedeon Richter Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 49. GenSci Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 50. Teva Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 51. ChangChun High & New Technology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 52. ABL Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 53. Scripps Laboratories Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 54. Alphamab Oncology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 55. Hunan Jingfeng Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 56. Qilu Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 57. Beijing SL Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed